[go: up one dir, main page]

AU2002226074A1 - E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof - Google Patents

E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof

Info

Publication number
AU2002226074A1
AU2002226074A1 AU2002226074A AU2607402A AU2002226074A1 AU 2002226074 A1 AU2002226074 A1 AU 2002226074A1 AU 2002226074 A AU2002226074 A AU 2002226074A AU 2607402 A AU2607402 A AU 2607402A AU 2002226074 A1 AU2002226074 A1 AU 2002226074A1
Authority
AU
Australia
Prior art keywords
stce
coli
binding protein
esterase inhibitor
esterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226074A
Inventor
Wyndham W. Lathem
Rodney A. Welch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of AU2002226074A1 publication Critical patent/AU2002226074A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002226074A 2000-10-26 2001-10-26 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof Abandoned AU2002226074A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24367500P 2000-10-26 2000-10-26
US60/243,675 2000-10-26
PCT/US2001/047719 WO2002034918A2 (en) 2000-10-26 2001-10-26 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof

Publications (1)

Publication Number Publication Date
AU2002226074A1 true AU2002226074A1 (en) 2002-05-06

Family

ID=22919663

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226074A Abandoned AU2002226074A1 (en) 2000-10-26 2001-10-26 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof

Country Status (3)

Country Link
US (1) US6872559B2 (en)
AU (1) AU2002226074A1 (en)
WO (1) WO2002034918A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264922B2 (en) * 2000-10-26 2007-09-04 Wisconsin Alumni Research Foundation Method of reducing complement - mediated disruption of cells
US7214479B2 (en) * 2000-10-26 2007-05-08 Wisconsin Alumni Research Foundation E. coli O157:H7 C1-INH-binding protein and methods of use
WO2013172954A1 (en) * 2012-05-17 2013-11-21 Ra Pharmaceuticals, Inc Peptide and peptidomimetic inhibitors
WO2014186622A2 (en) * 2013-05-15 2014-11-20 Annexon, Inc. Methods of treatment for guillain-barre syndrome
SG11201510316UA (en) 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
PL3215527T3 (en) 2014-11-05 2025-04-28 Annexon, Inc. Humanized anti-complement factor c1q antibodies and uses thereof
AU2016361517C1 (en) 2015-11-24 2024-06-06 Annexon, Inc. Anti-complement factor C1q Fab fragments and uses thereof
US12486322B2 (en) 2021-12-13 2025-12-02 Annexon, Inc. Anti-complement factor C1q antibodies with single binding arms and uses thereof

Also Published As

Publication number Publication date
US6872559B2 (en) 2005-03-29
WO2002034918A2 (en) 2002-05-02
WO2002034918A3 (en) 2003-01-30
US20020160433A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AUPR688101A0 (en) Protein domains and their ligands
AU6058500A (en) Fusion protein and uses thereof
AU5340399A (en) Proteases and associated proteins
AU2002226074A1 (en) E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof
AU1479400A (en) Milk protein dispersions
AU2001274566A1 (en) Novel protein and dna thereof
AU2533299A (en) Microbial assay
AU2001237592A1 (en) Enzymes and uses relating thereto
AU5196699A (en) Novel gene and protein pgth encoded thereby
AU3955099A (en) Novel gene and protein encoded thereby
AU2001241880A1 (en) 2504, 15977, and 14760, novel protein kinase family members and uses therefor
AU3411999A (en) Novel rnase-like protein and its use
AU5672999A (en) Maize repair protein orthologue-1 and uses thereof
AU5034200A (en) Oxidoreductase proteins
AU2002239235A1 (en) Gpcr-like protein and nucleic acids encoding same
AU2001250047A1 (en) Effector-specific protein assembly and uses thereof
AU2001274563A1 (en) Novel polypeptide and its dna
AU2001234150A1 (en) Novel protein and gene encoding the same
AU5196799A (en) Novel gene and protein osbh encoded thereby
AU2001282259A1 (en) Nucleic acids and pathogenic e.coli proteins, and their uses
AU2001278777A1 (en) Irap-binding protein
AU1999300A (en) An e. coli protein tyrosine kinase and its uses
AU2001230560A1 (en) Novel gene tig104alpha and protein tig104alpha encoded thereby
AU2001273447A1 (en) Tetraspan protein and uses thereof